SCHEMBL6473972

SCHEMBL6473972

O=C(O)CCc1ccc(OCC=C(c2ccc(-c3cccs3)cc2)c2ccc(-c3cccs3)cc2)c(I)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 3/20 0.50
PPARD Q03181 4/20 0.49
HDAC1 Q13547 4/20 0.41
TNFRSF1A P19438 4/20 0.39
PPARG P37231 1/20 0.38
GPR17 Q13304 1/20 0.38
KDM4E B2RXH2 1/20 0.38
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MMP2 P08253 1/20 0.38
MMP10 P09238 1/20 0.38
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
MMP12 P39900 1/20 0.38
MMP13 P45452 1/20 0.38
MMP14 P50281 1/20 0.38
HDAC2 Q92769 1/20 0.37
S1PR1 P21453 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6481705 0.90 PPARD (0.51) FFAR1PPARDHDAC1TNFRSF1APPARG
SCHEMBL6482964 0.89 PPARD (0.54) FFAR1PPARDHDAC1TNFRSF1APPARG
SCHEMBL6480865 0.89 PPARD (0.54) FFAR1PPARDHDAC1TNFRSF1APPARG
SCHEMBL6529335 0.87 FFAR1 (0.60) FFAR1PPARDPPARG
SCHEMBL6480530 0.84 PPARD (0.65) FFAR1PPARDPPARG
SCHEMBL6483729 0.83 FFAR1 (0.48) FFAR1PPARDHDAC1PPARGHDAC2
SCHEMBL6483699 0.83 FFAR1 (0.57) FFAR1PPARDPPARG
SCHEMBL6482415 0.81 FFAR1 (0.55) FFAR1PPARD
SCHEMBL6474071 0.81 FFAR1 (0.55) FFAR1PPARDPPARG
SCHEMBL6474478 0.81 PPARD (0.52) FFAR1PPARDPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6869967-B2 Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives NOVO NORDISK A/S (DK) 2005-03-22 US claimed
EP-1414778-A1 NOVEL VINYL CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ANTIDIABETICS ETC. NOVO NORDISK A/S (DK) 2004-05-06 EP claimed
US-20030139473-A1 Novel compounds, their preparation and use VTVX HOLDINGS II LLC 2003-07-24 US claimed
WO-2003011807-A1 NOVEL VINYL CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ANTIDIABETICS ETC. NOVO NORDISK A/S (DK) 2003-02-13 WO claimed
US-6869967-B2 Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives NOVO NORDISK A/S (DK) 2005-03-22 US disclosed
US-20030139473-A1 Novel compounds, their preparation and use VTVX HOLDINGS II LLC 2003-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139473-A1 Novel compounds, their preparation and use PPARG, PPARD, PPARA FFAR1 22/4885PPARD 2/4885HDAC1 1410/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.